British researchers have been examining and pooling data from a wide range of international studies — including Argentina, Bangladesh, Iran, Pakistan, Spain, Egypt, India and the USA — and found that the anti-parasitic medicine Ivermectin not only r…
British researchers have been examining and pooling data from a wide range of international studies — including Argentina, Bangladesh, Iran, Pakistan, Spain, Egypt, India and the USA — and found that the anti-parasitic medicine Ivermectin not only reduces deaths from Covid-19 but can be used to protect doctors and nurses, as well as others who have had contact with ill people, from getting the virus.
One report on the drug was published recently by an independent UK-based medical research company, the Evidence-Based Medicine Consultancy Ltd (E-BMC).
Similar research has been conducted by Dr Andrew Hill of the University of Liverpool and funded by the World Health Organization (WHO) as part of its Access to Covid-19 Tools (ACT) Accelerator programme.
The research also backs up recent findings from the US by Dr Pierre Kory and clinical experts of the Front Line Covid-19 Critical Care Alliance (FLCCC).
Doctors estimate that Ivermectin probably reduces the risk of a person dying from Covid-19 by between 65% and 95%.
In addition, some researchers are calling for Ivermectin to be offered as a prophylactic measure to health care workers.
Commenting on the research, Dr Tess Lawrie of the E-BMC, said, “This is really good news. Ivermectin will have a significant impact on the battle against Covid-19.
“It also offers great hope for the better protection of our doctors and nurses who are on the front lines of this terrible crisis, as well as the protection of those who have had ‘contacts’ with sick people.
“Ivermectin is a well-known, safe and inexpensive medicine that is currently unlicensed in the UK for human use.
“This research is the integration of global efforts by clinicians, researchers, and study participants to make a difference in the fight against Covid-19. We owe a debt of thanks to them all.”
https://app.croneri.co.uk/whats-new/british-research-ivermectin-treatment-covid-19
